Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
954
archived clinical trials in
Fibromyalgia

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Meridien Research
mi
from
St Petersburg, FL
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Meridien Research
mi
from
St Petersburg, FL
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Medical Research and Health Education Foundation, Inc.
mi
from
Columbus, GA
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Medical Research and Health Education Foundation, Inc.
mi
from
Columbus, GA
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Heartland Research Associates, LLC
mi
from
Wichita, KA
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Heartland Research Associates, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Boston Clinical Trials, INC.
mi
from
Boston, MA
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Boston Clinical Trials, INC.
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Quality Clinical Research, Inc.
mi
from
Omaha, NE
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Quality Clinical Research, Inc.
mi
from
Omaha, NE
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Social Psychiatry Research Institute
mi
from
Brooklyn, NY
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Social Psychiatry Research Institute
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
University of Cincinnati
mi
from
Cincinnati, OH
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Radiant Research, Inc.
mi
from
Akron, OH
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Radiant Research, Inc.
mi
from
Akron, OH
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Midwest Clinical Research Center
mi
from
Dayton, OH
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Sunstone Medical Research, LLC
mi
from
Medford, OR
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Sunstone Medical Research, LLC
mi
from
Medford, OR
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Clinical Research Center of Reading, LLP
mi
from
Wyomissing, PA
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Clinical Research Center of Reading, LLP
mi
from
Wyomissing, PA
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Behavioral Medicine Center
mi
from
Wyomissing, PA
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Behavioral Medicine Center
mi
from
Wyomissing, PA
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Costal Medical
mi
from
East Greenwich, RI
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Costal Medical
mi
from
East Greenwich, RI
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Omega Medical Research
mi
from
Warwick, RI
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Omega Medical Research
mi
from
Warwick, RI
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Coastal Carolina Research Center
mi
from
Mt Pleasant, SC
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Coastal Carolina Research Center
mi
from
Mt Pleasant, SC
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
FutureSearch Trials of Neurology
mi
from
Austin, TX
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
FutureSearch Trials of Neurology
mi
from
Austin, TX
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
The Fatigue Consultation Clinic
mi
from
Salt Lake City, UT
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
The Fatigue Consultation Clinic
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Lifetree Clinical Research, LC
mi
from
Salt Lake City, UT
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Lifetree Clinical Research, LC
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Charlottesville Medical Research
mi
from
, VA
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Charlottesville Medical Research
mi
from
, VA
Click here to add this to my saved trials
TD-9855 Mass Balance Study
An Open-Label Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of TD-9855 Following a Single Oral Dose Containing Approximately 100 µCi [14C]-Labeled TD-9855 (20 mg) in Healthy Subjects
Status: Enrolling
Updated:  8/15/2013
TBD
mi
from
, CA
TD-9855 Mass Balance Study
An Open-Label Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of TD-9855 Following a Single Oral Dose Containing Approximately 100 µCi [14C]-Labeled TD-9855 (20 mg) in Healthy Subjects
Status: Enrolling
Updated: 8/15/2013
TBD
mi
from
, CA
Click here to add this to my saved trials
Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients
Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients
Status: Enrolling
Updated:  9/23/2013
Center for Musculoskeletal Pain Research
mi
from
Gainesville, FL
Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients
Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients
Status: Enrolling
Updated: 9/23/2013
Center for Musculoskeletal Pain Research
mi
from
Gainesville, FL
Click here to add this to my saved trials
Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia
Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia - A Pilot Study
Status: Enrolling
Updated:  12/31/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia
Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia - A Pilot Study
Status: Enrolling
Updated: 12/31/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Eszopiclone in the Treatment of Insomnia and Fibromyalgia
Eszopiclone in the Treatment of Insomnia and Associated Symptoms of Fibromyalgia
Status: Enrolling
Updated:  2/19/2014
Department of Psychiatry, UMDNJ-Robert Wood Johnson Medical School
mi
from
Piscataway, NJ
Eszopiclone in the Treatment of Insomnia and Fibromyalgia
Eszopiclone in the Treatment of Insomnia and Associated Symptoms of Fibromyalgia
Status: Enrolling
Updated: 2/19/2014
Department of Psychiatry, UMDNJ-Robert Wood Johnson Medical School
mi
from
Piscataway, NJ
Click here to add this to my saved trials
Low Dose Naltrexone (LDN) Immune Monitoring
Low Dose Naltrexone (LDN) Immune Monitoring
Status: Enrolling
Updated:  4/7/2014
Stanford University School of Medicine
mi
from
Palo Alto, CA
Low Dose Naltrexone (LDN) Immune Monitoring
Low Dose Naltrexone (LDN) Immune Monitoring
Status: Enrolling
Updated: 4/7/2014
Stanford University School of Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - University of Michigan
A Phase 2 Clinical Trial Evaluating Use of the NeuroPoint Medical Device as a Treatment for Fibromyalgia.
Status: Enrolling
Updated:  8/5/2014
University of Michigan
mi
from
Ann Arbor, MI
A Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - University of Michigan
A Phase 2 Clinical Trial Evaluating Use of the NeuroPoint Medical Device as a Treatment for Fibromyalgia.
Status: Enrolling
Updated: 8/5/2014
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Los Angeles, CA
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Santa Ana, CA
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Coral Gables, FL
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Delray Beach, FL
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Delray Beach, FL
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
North Miami Beach, FL
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Orlando, FL
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Columbus, GA
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Columbus, GA
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Lawrenceville, GA
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Louisville, KY
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Worcester, MA
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Worcester, MA
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
St. Louis, MO
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Durham, NC
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Raleigh, NC
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Akron, OH
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Boardman, OH
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Boardman, OH
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Cincinnati, OH
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Columbus, OH
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Philadelphia, PA
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Charleston, SC
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Myrtle Beach, SC
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated:  8/18/2014
Pfizer Investigational Site
mi
from
Salt Lake City, UT
Adolescent Fibromyalgia Study
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Status: Enrolling
Updated: 8/18/2014
Pfizer Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Using Saline for Myofascial Pain Syndromes (USAMPS)
Using Saline for Myofascial Pain Syndromes (USAMPS)
Status: Enrolling
Updated:  6/11/2015
Lyndon Baines Johnson General Hospital
mi
from
Houston, TX
Using Saline for Myofascial Pain Syndromes (USAMPS)
Using Saline for Myofascial Pain Syndromes (USAMPS)
Status: Enrolling
Updated: 6/11/2015
Lyndon Baines Johnson General Hospital
mi
from
Houston, TX
Click here to add this to my saved trials